Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2017   87,153       3,973
Beginning Balance at Dec. 31, 2017 $ 501,875 $ 87 $ 637,851 $ 243 $ (75,046) $ (61,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Public offering of common stock (in shares)   8,050        
Public offering of common stock, net of $17,051 of offering costs 441,799 $ 8 441,791      
Issuance of common stock in connection with our acquisitions (in shares)   1,265        
Issuance of common stock in connection with our acquisitions 56,611 $ 1 56,610      
Stock option exercises (in shares)   18       367
Stock option exercises 7,739   5,469     $ 2,270
Issuance of restricted stock (in shares)           1,533
Issuance of restricted stock 0   (6,394)     $ 6,394
Treasury stock purchase, at cost (in shares)           453
Treasury stock purchased, at cost (14,760)   4     $ (14,764)
Stock-based compensation 24,500   24,500      
Other comprehensive income - derivative instruments 123     123    
Foreign currency translation (113)     (113)    
Net income 19,380       19,380  
Ending Balance (in shares) at Jun. 30, 2018   96,486       2,526
Ending Balance at Jun. 30, 2018 1,039,375 $ 96 1,159,831 253 (53,445) $ (67,360)
Beginning Balance (in shares) at Mar. 31, 2018   87,160       2,653
Beginning Balance at Mar. 31, 2018 522,027 $ 87 651,996 275 (61,924) $ (68,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Public offering of common stock (in shares)   8,050        
Public offering of common stock, net of $17,051 of offering costs 441,799 $ 8 441,791      
Issuance of common stock in connection with our acquisitions (in shares)   1,265       0
Issuance of common stock in connection with our acquisitions 56,611 $ 1 56,610      
Stock option exercises (in shares)   11       126
Stock option exercises 2,701   431     $ 2,270
Issuance of restricted stock (in shares)           197
Issuance of restricted stock 0   (5,091)     $ 5,091
Treasury stock purchase, at cost (in shares)           196
Treasury stock purchased, at cost (6,310)   4     $ (6,314)
Stock-based compensation 14,090   14,090      
Other comprehensive income - derivative instruments (36)     (36)    
Foreign currency translation 14     14    
Net income 8,479       8,479  
Ending Balance (in shares) at Jun. 30, 2018   96,486       2,526
Ending Balance at Jun. 30, 2018 1,039,375 $ 96 1,159,831 253 (53,445) $ (67,360)
Beginning Balance (in shares) at Dec. 31, 2018   95,991       2,341
Beginning Balance at Dec. 31, 2018 1,063,024 $ 96 1,187,683 (492) (58,793) $ (65,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with our acquisitions (in shares)   154        
Issuance of common stock in connection with our acquisitions 9,846   9,846      
Stock option exercises (in shares)   19       138
Stock option exercises 3,069   (1,277)     $ 4,346
Issuance of restricted stock (in shares)           1,268
Issuance of restricted stock 0   (38,999)     $ 38,999
Treasury stock purchase, at cost (in shares)           369
Treasury stock purchased, at cost (11,108)   1,620     $ (12,728)
Retirement of treasury stock (in shares)   (12)       (12)
Retirement of treasury stock 0   (152)   (592) $ 744
Stock-based compensation 31,154   31,154      
Other comprehensive income - derivative instruments (2,020)     (2,020)    
Foreign currency translation 19     19    
Net income 26,335       26,335  
Ending Balance (in shares) at Jun. 30, 2019   96,152       1,292
Ending Balance at Jun. 30, 2019 1,120,319 $ 96 1,189,875 (2,468) (33,075) $ (34,109)
Beginning Balance (in shares) at Mar. 31, 2019   95,998       1,265
Beginning Balance at Mar. 31, 2019 1,085,375 $ 96 1,167,950 (1,372) (47,546) $ (33,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with our acquisitions (in shares)   154        
Issuance of common stock in connection with our acquisitions 9,846   9,846      
Stock option exercises (in shares)   12       49
Stock option exercises 1,192   (440)     $ 1,632
Issuance of restricted stock (in shares)           138
Issuance of restricted stock 0   (4,543)     $ 4,543
Treasury stock purchase, at cost (in shares)           226
Treasury stock purchased, at cost (6,092)   1,183     $ (7,275)
Retirement of treasury stock (in shares)   (12)       (12)
Retirement of treasury stock     (152)   (592) $ 744
Stock-based compensation 16,031   16,031      
Other comprehensive income - derivative instruments (1,214)     (1,214)    
Foreign currency translation 118     118    
Net income 15,063       15,063  
Ending Balance (in shares) at Jun. 30, 2019   96,152       1,292
Ending Balance at Jun. 30, 2019 $ 1,120,319 $ 96 $ 1,189,875 $ (2,468) $ (33,075) $ (34,109)